These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 26184702
1. Continuous vs. intermittent vancomycin therapy for Gram-positive infections not caused by methicillin-resistant Staphylococcus aureus. Duszynska W, Taccone FS, Hurkacz M, Wiela-Hojenska A, Kübler A. Minerva Anestesiol; 2016 Mar; 82(3):284-93. PubMed ID: 26184702 [Abstract] [Full Text] [Related]
5. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia. Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD. Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788 [Abstract] [Full Text] [Related]
8. Evaluation of clinical outcome in children and adolescents receiving vancomycin for invasive infections due to methicillin-resistant Staphylococcus aureus: impact of increasing vancomycin MICs. Arun A, Swamy S, Jacob K, Sharma R, Kohlhoff SA, Hammerschlag MR. Minerva Pediatr; 2018 Jun; 70(3):207-211. PubMed ID: 28006894 [Abstract] [Full Text] [Related]
10. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus. Jaruratanasirikul S, Julamanee J, Sudsai T, Saengsuwan P, Jullangkoon M, Ingviya N, Jarumanokul R. J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996 [Abstract] [Full Text] [Related]
11. Pharmacokinetic/pharmacodynamic analysis of vancomycin in patients with Enterococcus faecium bacteraemia: a retrospective cohort study. Tochikura N, Matsumoto C, Iwabuchi S, Aso H, Fukushima S, Ootsuka S, Ooba N, Ishihara M, Nakajima H, Umemura H, Nakayama T. Eur J Hosp Pharm; 2024 Aug 22; 31(5):440-446. PubMed ID: 36868850 [Abstract] [Full Text] [Related]
13. The dosing and monitoring of vancomycin: what is the best way forward? Drennan PG, Begg EJ, Gardiner SJ, Kirkpatrick CMJ, Chambers ST. Int J Antimicrob Agents; 2019 Apr 22; 53(4):401-407. PubMed ID: 30599240 [Abstract] [Full Text] [Related]